Molecular Basis for Action, Dysfunction and New Therapeutic Approaches

The 2010 Gordon Conference on Angiotensin will provide the platform for presenting and discussing cutting-edge experimental and clinical research on the important molecular, cellular and in vivo aspects of angiotensin biology. Sessions will focus on recent advances in the following areas:

• Angiotensin vaccines and updates on contemporary therapeutic approaches
• Genetics and epidemiology of renin-angiotensin system mutations
• New insights into angiotensin receptor activation and signaling
• Proteases and angiotensin-mediated cell and tissue remodeling
• New results on angiotensin converting enzymes
• Angiotensin and cell programming
• Angiotensin systems and translation to disease

Presentations will include substantial discussion with session leaders instructed to ensure that focused themes are considered in broader terms and implications for the future development of the field debated. The Conference will assemble leading investigators at the forefront of this biologically and clinically relevant discipline. Central to the meeting will be the chance for early career scientists and graduate students to present their work as posters and short talks and to exchange ideas with the leaders in the field. The Gordon Conference on Angiotensin is collegial with informal gatherings in the afternoons and evenings to balance the programmed discussion sessions. The goal is to provide opportunities for scientific speculation, integration and collaboration across the various research areas.